Vanguard reports 0% stake in Medpace (amendment)
The Vanguard Group filed an Amendment No. 7 to its Schedule 13G/A reporting 0 shares and 0% beneficial ownership of Medpace Holdings Inc. common stock following an internal realignment described in the filing.
Rhea-AI Filing Summary
The Vanguard Group filed an Amendment No. 7 to its Schedule 13G/A reporting 0 shares and 0% beneficial ownership of Medpace Holdings Inc. common stock following an internal realignment described in the filing.
The amendment explains certain Vanguard subsidiaries and business divisions will report ownership separately under SEC Release No. 34-39538; the filing is signed by Ashley Grim on 03/27/2026.
Positive
- None.
Negative
- None.
Insights
Vanguard disaggregated holdings and now reports no beneficial ownership of MEDP shares.
The Vanguard Group states it no longer has beneficial ownership over securities held by certain subsidiaries after an internal realignment, citing SEC Release No. 34-39538. The filing records an ownership amount of 0 and 0%.
Cash‑flow treatment and specific subsidiary holdings are not detailed in the excerpt; subsequent filings by the named subsidiaries may disclose their separate beneficial positions.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does The Vanguard Group report for MEDP ownership?
Why does Vanguard show zero ownership after the amendment?
Who signed the Schedule 13G/A amendment for Vanguard?
Does this filing disclose subsidiary holdings in MEDP?
Is Vanguard still involved with dividend or sale rights for these securities?
AI-generated analysis. How Rhea-AI works. Not financial advice.